- Total of six poster presentations analyze the effects of treatment with enzyme replacement therapies in Fabry disease and alpha-mannosidosis -- ...

Related Keywords

Versailles , Îe De France , France , Boston , Massachusetts , United States , Sweden , Israel , China , United Kingdom , Jerusalem , Israel General , Canada , Italy , Dominique Germain , David Warnock , John Bernat , Derralynn Hughes , Giacomo Chiesi , Angela Messina , Armand Trousseau , Alessio Pappagallo , Chiara Travagin , Ozlem Goker Alpan , Consiglio Nazionale Delle Ricerche , Benedicte Heron , Adam Daley , Treatment Center , University Of Versailles , Access Program , University College London , Chiesi Group , Reference Centre For Lysosomal Diseases , Rare Disorders Research , B Corp , University Of Alabama At Birmingham , Roche Guyon University Hospital , University Of Iowa Hospitals , Division Of Medical Genetics , Department Of Pediatric Neurology , Emory University School Of Medicine , Berry Company Public Relations , Chiesi Group Media Contacts , Chiesi Global Rare Diseases , Inborn Errors , Annual Symposium , Chiesi Global Rare , Iowa Hospitals , Expanded Access , Fabry Disease Monitoring , Medical Genetics , Royal Free , Dawn Laney , Emory University School , Pediatric Neurology , Preference Centre , Lysosomal Diseases , Consiglio Nazionale , Important Safety Information , Full Prescribing Information , Hypersensitivity Reactions , Infusion Associated Reactions , Associated Reactions , Reproductive Potential , Global Rare Diseases , Benefit Corporation , Global Rare ,